The United Kingdom is forecast to grow at 4.8%, benefitting from strong consumer awareness and demand for energy-boosting supplements, while the United States records a steady 4.3% CAGR as established players expand e-commerce distribution and clinical applications
However, the high development cost of GLP-1 drugs can hamper the global GLP-1 receptor agonist market growth
In a comparison between GLP-1RAs and SGLT2 inhibitors, 105,794 patients were included in the GLP-1RA cohort, and 69,826 patients were in the SGLT2 inhibitor cohort
Stress: Chronic stress can have a negative impact on overall gut health and DAO production
Trusted UK supplier with fast delivery We supply premium-grade Retatrutide, Tirzepatide and other peptides designed for laboratory research, ensuring high purity, consistency, and reliable sourcing standards
11h, i)